University of Adelaide Library

Adelaide Research and Scholarship : Schools and Disciplines : School of Medical Sciences : Pharmacology : Pharmacology Publications

Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/74294

Type: Journal article
Title: Morphine activates neuroinflammation in a manner parallel to endotoxin
Author: Wang, Xiaohui
Loram, Lisa C.
Ramos, Khara M.
de Jesus, Armando J.
Thomas, Jacob Henry Lloyd
Cheng, Kui
Reddy, Annireddy
Somogyi, Andrew Alexander
Hutchinson, Mark Rowland
Watkins, Linda R.
Yin, Hang
Citation: Proceedings of the National Academy of Sciences of the United States of America, 2012; 109(16):6325-6330
Publisher: National Academy of Sciences
Issue Date: 2012
ISSN: 0027-8424
School/Discipline: School of Medical Sciences : Pharmacology
Statement of
Responsibility: 
Xiaohui Wang, Lisa C. Loram, Khara Ramos, Armando J. de Jesus, Jacob Thomas, Kui Cheng, Anireddy Reddy, Andrew A. Somogyi, Mark R. Hutchinson, Linda R. Watkins and Hang Yin
Abstract: Opioids create a neuroinflammatory response within the CNS, compromising opioid-induced analgesia and contributing to various unwanted actions. How this occurs is unknown but has been assumed to be via classic opioid receptors. Herein, we provide direct evidence that morphine creates neuroinflammation via the activation of an innate immune receptor and not via classic opioid receptors. We demonstrate that morphine binds to an accessory protein of Toll-like receptor 4 (TLR4), myeloid differentiation protein 2 (MD-2), thereby inducing TLR4 oligomerization and triggering proinflammation. Small-molecule inhibitors, RNA interference, and genetic knockout validate the TLR4/MD-2 complex as a feasible target for beneficially modifying morphine actions. Disrupting TLR4/MD-2 protein–protein association potentiated morphine analgesia in vivo and abolished morphine-induced proinflammation in vitro, the latter demonstrating that morphine-induced proinflammation only depends on TLR4, despite the presence of opioid receptors. These results provide an exciting, nonconventional avenue to improving the clinical efficacy of opioids.
Keywords: Protein–protein interaction; pain management therapy; drug discovery
Rights: © Authors
RMID: 0020118494
DOI: 10.1073/pnas.1200130109
Appears in Collections:Pharmacology Publications
View citing articles in: Google Scholar
Scopus

Files in This Item:

File Description SizeFormat
hdl_74294.pdfPublished version674.52 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

© 2008 The University of Adelaide
library@adelaide.edu.au
CRICOS Provider Number 00123M
Service Charter | Copyright | Privacy | Disclaimer